Go Back   ISPINE.ORG Forum > Main forums > iSpine
FAQ Members List Calendar Today's Posts

iSpine Discuss medicine alert in the Main forums forums; Warning: Fluoroquinolone Antibiotics Linked to Nerve Damage The FDA is requiring the drug labels and Medication Guides for all fluoroquinolone ...

 
 
LinkBack Thread Tools Display Modes
Prev Previous Post   Next Post Next
  #1 (permalink)  
Old 08-19-2013, 05:48 PM
Senior Member
 
Join Date: Sep 2006
Posts: 2,405
Default medicine alert

Warning: Fluoroquinolone Antibiotics Linked to Nerve Damage

The FDA is requiring the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated with the serious side effect of peripheral neuropathy. The nerve damage may occur soon after these drugs are taken by mouth or by injection, and may be permanent.

RELATED CHART: Antibiotic Formulations

The affected fluoroquinolone drugs include: Levaquin (levofloxacin; Janssen), Cipro (ciprofloxacin; Bayer), Avelox (moxifloxacin; Bayer), Noroxin (norfloxacin; Merck), Factive (gemifloxacin; Cornerstone), and Ofloxacin.

Topical formulations indicated for the ears or eyes are not known to be associated with this risk.

RELATED: Infectious Diseases Resource Center

The FDA recommends discontinuing the fluoroquinolone if the patient develops symptoms of peripheral neuropathy. The patient should be switched to another, non-fluoroquinolone antibiotic unless the benefit outweighs the risk. Symptoms include pain, burning, tingling, numbness, weakness, or a change in sensation to light touch, pain or temperature, or the sense of body position.
For more information call (888) 463-6332 or visit FDA.gov.

]
Reply With Quote
 

Bookmarks


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT. The time now is 08:36 AM.


Powered by vBulletin® Version 3.7.2
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.